This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
News|Articles|April 27, 2016
Nemera Wins ‘Best New Product’ at INTERPHEX
Author(s)Pharmaceutical Technology Editors
The company’s preservative-free multidose eyedropper wins award.
Advertisement
Nemera’s Novelia BFS, a preservative-free multi-dose eyedropper, received the ‘Best New Product’ INTERPHEX Exhibitor Award at
According to a company press release, Novelia is user-friendly, “works with high viscosity suspensions and solutions of up to 1500 cps, and limits the distribution of liquids to one drop at a time. The doses of the drops are precise, which assist medication adherence. Nemera and Rommelag combined their technologies and experiences to create a preservative-free multidose ophthalmic dropper processed by blow-fill-seal.”
The INTERPHEX Exhibitor Award evaluates submissions based on overall design, knowledge, innovation, new technology or novel implementation of existing technology, advances in features and performance, advances in services provision, significant new services additions, and showcasing of technical knowledge.
Source:
Advertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
5